AMO Corporation — Tallahassee, Florida

AMO Corporation is a clinical research site located in Tallahassee, Florida, United States 32308.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

AMO Corporation has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: Multiple Sclerosis, Relapsing Multiple Sclerosis, Partial Onset Seizures.

Sponsors: Novartis, Novartis Pharmaceuticals, Eisai Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tallahassee

Browse all research sites in Florida · View every site in Tallahassee

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AMO Corporation?

AMO Corporation has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AMO Corporation conducted?

AMO Corporation has 8 clinical trials on record, with 2 currently active. Their work covers Multiple Sclerosis, Relapsing Multiple Sclerosis, Partial Onset Seizures.

Is AMO Corporation accredited by Crixeo Clinical Trials?

AMO Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AMO Corporation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.